McDermott Will & Schulte has advised Sagard NewGen. Sagard NewGen has completed a minority investment in Quipment, a prominent provider of equipment solutions for clinical trials,…
Sagard NewGen Announces Minority Investment in Quipment


McDermott Will & Schulte has advised Sagard NewGen. Sagard NewGen has completed a minority investment in Quipment, a prominent provider of equipment solutions for clinical trials,…
…